Archives of Clinical Infectious Diseases

Published by: Kowsar

The Prevalence of Aminoglycoside-Modifying Enzyme Genes Among Pseudomonas aeruginosa Strains Isolated From Burn Patients

Mojtaba Kashfi 1 , Ali Hashemi 1 , Gita Eslami 1 , * , Mehrzad Sadredin Amin 1 , Samira Tarashi 1 and Elahe Taki 2
Authors Information
1 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Microbiology, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: January 2017, 12 (1); e40896
  • Published Online: December 11, 2016
  • Article Type: Research Article
  • Received: July 17, 2016
  • Revised: November 15, 2016
  • Accepted: December 5, 2016
  • DOI: 10.5812/archcid.40896

To Cite: Kashfi M, Hashemi A, Eslami G, Sadredin Amin M, Tarashi S, et al. The Prevalence of Aminoglycoside-Modifying Enzyme Genes Among Pseudomonas aeruginosa Strains Isolated From Burn Patients, Arch Clin Infect Dis. 2017 ; 12(1):e40896. doi: 10.5812/archcid.40896.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Heidary M, Hashemi A, Goudarzi H, Khoshnood S, Roshani M, Azimi H. The antibacterial activity of Iranian plants extracts against metallo beta-lactamase producing Pseudomonas aeruginosa strains. J Paramed Sci. 2016; 7(1)
  • 2. Park YS, Lee H, Chin BS, Han SH, Hong SG, Hong SK, et al. Acquisition of extensive drug-resistant Pseudomonas aeruginosa among hospitalized patients: risk factors and resistance mechanisms to carbapenems. J Hosp Infect. 2011; 79(1): 54-8[DOI][PubMed]
  • 3. Tadvi J, Javadekar T, Bhavsar R, Garala N. Prevalence & antibiogram of Pseudomonas aeruginosa at SSG Hospital, Baroda, Gujarat, India. J Res Med Dental Sci. 2015; 3(3): 204-7[DOI]
  • 4. Hashemi A, Fallah F, Erfanimanesh S, Chirani AS, Dadashi M. Detection of Antibiotic Resistance Genes among Pseudomonas aeruginosa Strains Isolated from Burn Patients in Iran. British Microbiol Res J. 2016; 12(4): 1-6
  • 5. Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2011; 2: 65[DOI][PubMed]
  • 6. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005; 49(2): 479-87[DOI][PubMed]
  • 7. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updat. 2010; 13(6): 151-71[DOI][PubMed]
  • 8. Doi Y, Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis. 2007; 45(1): 88-94[DOI][PubMed]
  • 9. Yamane K, Doi Y, Yokoyama K, Yagi T, Kurokawa H, Shibata N, et al. Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2004; 48(6): 2069-74[DOI][PubMed]
  • 10. Zhou Y, Yu H, Guo Q, Xu X, Ye X, Wu S, et al. Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides. Eur J Clin Microbiol Infect Dis. 2010; 29(11): 1349-53[DOI][PubMed]
  • 11. Wayne P. Clinical and Laboratory Standards Institute (CLSI) performance standards for antimicrobial disk diffusion susceptibility tests 2015;
  • 12. Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009; 49(11): 1749-55[DOI][PubMed]
  • 13. Aghazadeh M, Rezaee MA, Nahaei MR, Mahdian R, Pajand O, Saffari F, et al. Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among acinetobacter baumannii and Pseudomonas aeruginosa isolates. Microb Drug Resist. 2013; 19(4): 282-8[DOI][PubMed]
  • 14. Asadollahi P, Akbari M, Soroush S, Taherikalani M, Asadollahi K, Sayehmiri K, et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns. 2012; 38(8): 1198-203[DOI][PubMed]
  • 15. Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, Andre C, et al. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J Antimicrob Chemother. 2008; 62(2): 316-23[DOI][PubMed]
  • 16. Chatterjee M, Anju CP, Biswas L, Anil Kumar V, Gopi Mohan C, Biswas R. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options. Int J Med Microbiol. 2016; 306(1): 48-58[DOI][PubMed]
  • 17. Rastegar Lari AR, Alaghehbandan R, Akhlaghi L. Burn wound infections and antimicrobial resistance in tehran, iran: an increasing problem. Ann Burns Fire Disasters. 2005; 18(2): 68-73[PubMed]
  • 18. Kiani M, Zandi H, Astani A, Vakili M, Musavi M, Zarei M. Investigating Antibiotic Resistance in Pseudomonas Aeruginosa Strains Isolated from Various Clinical Specimens of Patients Referring to Hospitals in Yazd. J Shahid Sadoughi Uni Med Sci. 2015; 22(6): 1644-53
  • 19. Goudarzi H, Taherpour A, Fallah F, Pourkaveh B, Erfanimanesh S, Hashemi A. Laboratory Detection of Carbapenemases in Gram-Negative Bacteria. Arch Clin Infect Dis. 2016; [DOI]
  • 20. Michalska AD, Sacha PT, Ojdana D, Wieczorek A, Tryniszewska E. Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland. Braz J Microbiol. 2014; 45(4): 1455-8[DOI][PubMed]
  • 21. Bhatt P, Rathi KR, Hazra S, Sharma A, Shete V. Prevalence of multidrug resistant Pseudomonas aeruginosa infection in burn patients at a tertiary care centre. India J Burns. 2015; 23(1): 56[DOI]
  • 22. Vaziri F, Peerayeh SN, Nejad QB, Farhadian A. The prevalence of aminoglycoside-modifying enzyme genes (aac (6')-I, aac (6')-II, ant (2")-I, aph (3')-VI) in Pseudomonas aeruginosa. Clinics (Sao Paulo). 2011; 66(9): 1519-22[PubMed]
  • 23. Jafari M, Fallah F, Borhan RS, Navidinia M, Karimi A, Tabatabaei SR. The first report of CMY, aac (6′)-Ib and 16S rRNA methylase genes among Pseudomonas aeruginosa isolates from Iran. Arch Pediatr Infect Dis. 2013; 1(3): 109-12[DOI]
  • 24. Li J, Zou M, Dou Q, Hu Y, Wang H, Yan Q, et al. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China. Ann Clin Microbiol Antimicrob. 2016; 15(1): 35[DOI][PubMed]
  • 25. Odumosu BT, Adeniyi BA, Chandra R. Occurrence of aminoglycoside-modifying enzymes genes (aac(6')-I and ant(2'')-I) in clinical isolates of Pseudomonas aeruginosa from Southwest Nigeria. Afr Health Sci. 2015; 15(4): 1277-81[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments